The PDGFR-β was expressed in all adenoma subtypes as well as controls, with somatotropinomas showing higher expression compared to NFPA or control (59 vs. 20%, P < 0.001; Figures 2, 3). This evidence concerns the gene PDGFRB and growth hormone-producing pituitary gland neoplasm.